Skip To Main Content
Shu Long on Muck Rack

Shu Long

As seen in: Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shu

Contact Shu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Computer Science > Robotics

|
By Haozhuang Chi, Hao Su, Shu Long
| arxiv.org
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Open in Who Shared View Duplicates (502) Issue with article?

MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray data

|
By Lu Min, Wu Fang, Hu Chunhong, Shu Long
| Lung Cancer Verified
Highlights • 5-aza-2′-deoxycytidine reversed the cisplatin resistance of A549/DDP cells • MiR-320a was up-regulated in revering the cisplatin resistance • Target genes of miR-320a were found involved in tumor progression signaling pathway Abstract Background Currently, the main therapy for NSCLC is a surgery and chemotherapy. Although great progress has been made in targeted treatment and immunotherapy, the survival rates are still low which is associated with resistance to chemotherapy.
Open in Who Shared Issue with article?
See all 2 articles